RAFFA WEALTH MANAGEMENT, LLC’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23
Closed -$1.26K 1102
2024
Q4
$1.26K Hold
23
﹤0.01% 799
2024
Q3
$1.16K Hold
23
﹤0.01% 814
2024
Q2
$1.01K Hold
23
﹤0.01% 898
2024
Q1
$1.01K Hold
23
﹤0.01% 893
2023
Q4
$1.09K Hold
23
﹤0.01% 799
2023
Q3
$1.02K Hold
23
﹤0.01% 774
2023
Q2
$1.1K Hold
23
﹤0.01% 772
2023
Q1
$905 Hold
23
﹤0.01% 819
2022
Q4
$651 Hold
23
﹤0.01% 896
2022
Q3
$691 Hold
23
﹤0.01% 924
2022
Q2
$781 Hold
23
﹤0.01% 892
2022
Q1
$1.03K Hold
23
﹤0.01% 850
2021
Q4
$1.06K Hold
23
﹤0.01% 841
2021
Q3
$773 Hold
23
﹤0.01% 934
2021
Q2
$676 Hold
23
﹤0.01% 982
2021
Q1
$593 Buy
+23
New +$550 ﹤0.01% 1015

Other funds holding IRMD

RAFFA WEALTH MANAGEMENT, LLC's IRMD Position: Q1 2025 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of iRadimed (IRMD) in Q1 2025, closing a stake of 23 shares — an estimated $1.26K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in IRMD in Q1 2021 and held it in 16 quarters. The position peaked at $1.26K in Q4 2024. 168 funds tracked by Wall St. Rank hold IRMD as of Q1 2025.

  • RAFFA WEALTH MANAGEMENT, LLC reported no remaining iRadimed position as of Q1 2025 after selling out during the quarter.
  • RAFFA WEALTH MANAGEMENT, LLC sold 23 iRadimed shares in Q1 2025, an estimated $1.26K.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in iRadimed in Q1 2021 and held it in 16 quarters.
  • RAFFA WEALTH MANAGEMENT, LLC's iRadimed position peaked at $1.26K in Q4 2024.
  • 168 funds tracked by Wall St. Rank held iRadimed as of Q1 2025.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q1 2025, filed 27 Jul 2026.